Pyrimidines

On December 31, 2022, Oba, Yasuhiro; Takano, Yoshinori; Furukawa, Yoshihiro; Koga, Toshiki; Glavin, Daniel P.; Dworkin, Jason P.; Naraoka, Hiroshi published an article.Product Details of 626-48-2 The title of the article was Identifying the wide diversity of extraterrestrial purine and pyrimidine nucleobases in carbonaceous meteorites. And the article contained the following:

The lack of pyrimidine diversity in meteorites remains a mystery since prebiotic chem. models and laboratory experiments have predicted that these compounds can also be produced from chem. precursors found in meteorites. Here we report the detection of nucleobases in three carbonaceous meteorites using state-of-the-art anal. techniques optimized for small-scale quantification of nucleobases down to the range of parts per trillion (ppt). In addition to previously detected purine nucleobases in meteorites such as guanine and adenine, we identify various pyrimidine nucleobases such as cytosine, uracil, and thymine, and their structural isomers such as isocytosine, imidazole-4-carboxylic acid, and 6-methyluracil, resp. Given the similarity in the mol. distribution of pyrimidines in meteorites and those in photon-processed interstellar ice analogs, some of these derivatives could have been generated by photochem. reactions prevailing in the interstellar medium and later incorporated into asteroids during solar system formation. This study demonstrates that a diversity of meteoritic nucleobases could serve as building blocks of DNA and RNA on the early Earth. The experimental process involved the reaction of 6-Methylpyrimidine-2,4(1H,3H)-dione(cas: 626-48-2).Product Details of 626-48-2

The Article related to carbonaceous meteorite extraterrestrial purine pyrimidine nucleobase identifying wide diversity, Mineralogical and Geological Chemistry: Cosmochemistry and Meteorites and other aspects.Product Details of 626-48-2

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On October 31, 2018, Chestnova, T. V.; Zilov, V. G.; Gladkikh, P. G.; Khadartsev, A. A.; Korotkova, A. S.; Buzulukov, Yu. P. published an article.SDS of cas: 626-48-2 The title of the article was Combined Effect of Silver Nanoparticles, Ceftriaxone, and Methyluracil during Experimental Purulent Peritonitis. And the article contained the following:

Bacterial biofilms provoke and/or promote the most chronic and recurrent infectious diseases. Previously, exptl. models of purulent peritonitis and meningoencephalitis revealed pos. antibiofilm effect of metallic nanoparticles and the absence of resistance against such nanoparticles in microorganisms. This study examines the combined effect of silver nanoparticles with ceftriaxone and methyluracil on recovery mechanisms during inflammatory diseases exemplified by purulent peritonitis in exptl. animals. The experimental process involved the reaction of 6-Methylpyrimidine-2,4(1H,3H)-dione(cas: 626-48-2).SDS of cas: 626-48-2

The Article related to purulent peritonitis silver nanoparticle ceftriaxone methyluracil, bacterial biofilms, ceftriaxone, methyluracil, nanoparticles, peritonitis, Pharmacology: Effects Of Cardiovascular, Hematologic, and Renal Drugs and other aspects.SDS of cas: 626-48-2

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On August 31, 2021, Ting, Chien-Yu; Huang, Ching-Ying; Chen, Hung-Chih; Chiu, Yi-Wen; Hsieh, Patrick C. H.; Lee, Jia-Jung published an article.Synthetic Route of 65-71-4 The title of the article was Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation. And the article contained the following:

Bardet-Biedl syndrome is a autosomal recessive hereditary disorder characterized by polydactyly, multiple renal cysts, retinal cone-rod dystrophy, obesity, and variable neural development or cognitive impairment. We reported the generation and characterization of an iPS cell line, IBMS-iPSC-063-06, from a patient carrying the BBS2 homologous c534 + 1G > T mutation. The generated iPS cell line retains the mutation and exhibits pluripotency and differentiation ability both in vivo and in vitro condition. The experimental process involved the reaction of 5-Methylpyrimidine-2,4(1H,3H)-dione(cas: 65-71-4).Synthetic Route of 65-71-4

The Article related to bardet biedl syndrome induced pluripotent stem cell bbs2, Mammalian Pathological Biochemistry: Metabolic and Hereditary Diseases and other aspects.Synthetic Route of 65-71-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On September 18, 2014, Amans, Dominique; Atkinson, Stephen John; Harrison, Lee Andrew; Hirst, David Jonathan; Law, Robert Peter; Lindon, Matthew; Preston, Alexander; Seal, Jonathan Thomas; Wellaway, Christopher Roland published a patent.Application of 596114-50-0 The title of the patent was Preparation of acylaminotetrahydroquinoline derivatives for use as bromodomain inhibitors. And the patent contained the following:

Title compounds I [A = NH, O, S, SO, etc.; V = (un)substituted Ph, heteroaromatic, or pyridone; W and Z independently = CH or N; X or Y independently = C or N; R1 = alkyl; R2 = alkyl, cycloalkyl, heterocyclyl, CH2CF3, or CH2OMe; R3 = alkyl, CH2F, CH2OH, or CH2OC(O)Me; R4 = absent, H, OH, halo, CN, CO2H, etc.; R5 = absent, H, halo, OH, or alkoxy], and their pharmaceutically acceptable salts, are prepared and disclosed as bromodomain inhibitors. Thus, e.g., II was prepared by a multistep procedure (preparation given). Select I were evaluated in BRD4 BD2 TR-FRET assays, e.g., II demonstrated a pIC50 value of ≥7.0. The experimental process involved the reaction of 2-Chloro-5-isopropylpyrimidine(cas: 596114-50-0).Application of 596114-50-0

The Article related to quinoline acylaminotetrahydro preparation bromodomain inhibitor, Heterocyclic Compounds (One Hetero Atom): Quinolines and Isoquinolines and other aspects.Application of 596114-50-0

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On November 11, 1987, Jooji, Eru Euansu; Debora, Eru Deuookusu published a patent.Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Pathogenic Neisseria-specific growth medium and its use in clinical diagnosis. And the patent contained the following:

A medium containing vancomycin (I) and lincomycin (II) for selectively growing Neisseria is prepared Its use in clin. diagnosis of pathogenic Neisseria such as N. gonorrhoeae or N. meningitidis is also disclosed. An agar medium containing GC agar base 36.0, Hb 10.0 g/L, Isovitalex enrichment 10.0 mL/L, I 2.0 mg/L, II 1.0, colistin sulfate 7.5, trimethoprim 5.0, amphotericin B 5.0 μg/L, and nystatin 1250 units/L was prepared and tested for its selectivity. The growth of N. gonorrhoeae and N. meningitidis was excellent while growth of other microorganisms such as yeast was inhibited. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate

The Article related to neiserria pathogen selection culture medium, vancomycin lincomycin neiserria pathogen selection, Fermentation and Bioindustrial Chemistry: Methods (Including Analysis) and other aspects.Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Stone, K. John published an article in 1976, the title of the article was The role of tetrahydrofolate dehydrogenase in the hepatic supply of tetrahydrobiopterin in rats.Formula: C17H24N4O6 And the article contains the following content:

The reduction of 7,8-dihydrobiopterin (I) to 5,6,7,8-tetrahydrobiopterin by tetrahydrofolate dehydrogenase (EC 1.5.1.3) purified from rat liver was competitively inhibited by trimethoprim lactate (II) (0.36-50.mu.M, Ki 0.285.mu.M). The apparent Km for I was 430 times higher than that for dihydrofolate; reduction of I is thus more susceptible to inhibition by II than is dihydrofolate. I.p. administration of II had no effect on the hepatic supply of tetrahydrobiopterin in rats. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Formula: C17H24N4O6

The Article related to liver tetrahydrofolate dehydrogenase tetrahydrobiopterin, trimethoprim liver tetrahydrofolate dehydrogenase, Enzymes: Substrates-Cofactors-Inhibitors-Activators-Coenzymes-Products and other aspects.Formula: C17H24N4O6

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On May 7, 2021, Krajewski, Allison E.; Lee, Jeehiun K. published an article.Reference of 5-(Hydroxymethyl)pyrimidine-2,4(1H,3H)-dione The title of the article was Gas-phase experimental and computational studies of 5-halouracils: Intrinsic properties and biological implications. And the article contained the following:

The gas-phase acidity and proton affinity (PA) of 5-halouracils (5-fluorouracil, 5-chlorouracil, 5-bromouracil, and 5-iodouracil) have been examined using both theor. and exptl. methods. This work represents a comprehensive study of the thermochem. properties of these nucleobases. Other than 5-fluorouracil acidity, the intrinsic acidity and PA of these halouracils have not been heretofore measured; these new exptl. data provide a benchmark for the computational values. Furthermore, we examine these 5-halouracils in the context of the enzyme thymine DNA glycosylase (TDG), which is an enzyme that protects the genome by cleaving these substrates from DNA. Our gas-phase results are compared and contrasted to TDG excision rates to afford insights into the TDG mechanism. The experimental process involved the reaction of 5-(Hydroxymethyl)pyrimidine-2,4(1H,3H)-dione(cas: 4433-40-3).Reference of 5-(Hydroxymethyl)pyrimidine-2,4(1H,3H)-dione

The Article related to human thymine dna glycosylase mechanism 5 halouracil antitumor agent, halouracil gas phase acidity proton affinity thymine dna glycosylase, Enzymes: Substrates-Cofactors-Inhibitors-Activators-Coenzymes-Products and other aspects.Reference of 5-(Hydroxymethyl)pyrimidine-2,4(1H,3H)-dione

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On November 11, 2015, Liang, Ruiyong; Gao, Hai published a patent.COA of Formula: C17H24N4O6 The title of the patent was An aqueous environmentally-friendly abrasion resistant coating. And the patent contained the following:

The title coating is prepared from alkyd resin 90-100, 1, 2- dimethoxyethane 1-2, aluminum borate whisker 3-5, volcanic ash 1-2, expanded perlite 3-4, polyvinyl alc. 2-3, dimethylaminopropylamine 0. 6-1, calcium naphthenate 0. 5-1, isooctyl methacrylate 2-4, magnesium stearate 1-3, manganese sulfate 0. 5-1, aluminum sulfate 1-2, stearic acid 0. 7-1, wollastonite powder 8-12, flame retardant additive 2-4, STPP 1-2, and deionized water 80-100 weight parts. The title coating is produced by mixing volcanic ash, expanded perlite and wollastonite powder, ball milling uniformly to obtain the grinding material; adding STPP into water, stirring uniformly, adding stearic acid and calcium naphthenate, stirring at 30-40 °C for 5-7 min to obtain the activation solution; adding the grinding material into the activation solution, stirring uniformly, adding dimethylaminopropylamine, stirring and dispersing at 100-200 rpm for 20-30 min to obtain the pre-mixture; mixing polyvinyl alc., Mn sulfate and Al sulfate, stirring and mixing at 50-60 °C for 3-5 min, adding above pre-mixture, stirring uniformly, adding 1,2-dimethoxyethane, the left deionized water and alkyd resin, stirring and dispersing at 300-400 rpm for 1-2 h, mixing with the left raw materials, stirring and dispersing at 600-1000 rpm for 20-30 min to obtain the title coating product. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).COA of Formula: C17H24N4O6

The Article related to alkyd resin abrasion resistant coating, Coatings, Inks, and Related Products: Polyester and Alkyd Resin Coatings and other aspects.COA of Formula: C17H24N4O6

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On December 3, 2021, Guo, Jianhua; Li, Mengru; Lu, Ying; Sun, Yue published a patent.Recommanded Product: 160377-42-4 The title of the patent was Preparation of compounds containing benzo five membered heterocycles and organic electroluminescent devices. And the patent contained the following:

The invention discloses a preparation of compounds containing benzo five membered heterocycles and organic electronic devices, which improves the luminous efficiency of the device and prolongs the service life of the device. The compounds containing benzo five membered heterocycles were shown in formula I, Y is selected from any one of O atom, S atom, C (Rx) 2 and N(Ry); the Rx and Ry are the same or different from each other, and are independently selected from hydrogen, deuterium, cyano, nitro, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl any one of the rings formed by the condensation of the substituted or unsubstituted aliphatic ring of C3- C30 and the aromatic ring of C6- C30; the two adjacent Rx can be connected to form a substituted or unsubstituted ring, or any of Rx and Ry can be directly bonded with L0; when the Rx and Ry are directly bonded with L0, the Rx and Ry are independently selected from any one of single bond, substituted or unsubstituted C6-C30 arylene, substituted or unsubstituted heteroarylene; the Z is selected from any one of O atom and S atom; the Ar1 is selected from substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C3-C12 heterocycloalkyl, etc. The title compound was prepared by a multi-step reaction. The invention discloses an organic electroluminescent device, which comprises the components containing benzo five member heterocycles. The experimental process involved the reaction of 5-(4-Bromophenyl)pyrimidine(cas: 160377-42-4).Recommanded Product: 160377-42-4

The Article related to benzo five membered heterocycle organic electroluminescent device suzuki coupling, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Recommanded Product: 160377-42-4

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

On September 30, 2015, Akbarzadeh, Marzieh; Bakavoli, Mehdi; Eshghi, Hossein; Shiri, Ali; Tajabadi, Javad published an article.Category: pyrimidines The title of the article was Synthesis of dihydrobenzo[b]pyrimido[4,5-e][1,4]thiazepines; derivatives of a novel ring system. And the article contained the following:

Several derivatives of the novel dihydrobenzo[b]pyrimido[4,5-e][1,4]thiazepine ring system I (NR1 = piperidinyl, morpholinyl, pyrrolidino, etc.) have been synthesized through the initial heterocyclization of 2,4-dichloro-5-(chloromethyl)-6-methylpyrimidine with o-aminothiophenol followed by treatment with various secondary amines in boiling ethanol. The experimental process involved the reaction of 6-Methylpyrimidine-2,4(1H,3H)-dione(cas: 626-48-2).Category: pyrimidines

The Article related to dihydrobenzopyrimidothiazepine preparation, chloromethylmethylpyrimidine aminothiophenol heterocyclization, Heterocyclic Compounds (More Than One Hetero Atom): Other 7-Membered Rings and other aspects.Category: pyrimidines

Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia